Free Trial

Heatwurx (PCSA) Competitors

Heatwurx logo
$0.23 0.00 (-1.61%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.23 +0.00 (+0.80%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PCSA vs. LSB, TLPH, DWTX, AEON, NLSP, CLRB, CHRO, KPRX, TSBX, and BMRA

Should you be buying Heatwurx stock or one of its competitors? The main competitors of Heatwurx include LakeShore Biopharma (LSB), Talphera (TLPH), Dogwood Therapeutics (DWTX), AEON Biopharma (AEON), NLS Pharmaceutics (NLSP), Cellectar Biosciences (CLRB), Chromocell Therapeutics (CHRO), Kiora Pharmaceuticals (KPRX), Turnstone Biologics (TSBX), and Biomerica (BMRA). These companies are all part of the "pharmaceutical products" industry.

Heatwurx vs. Its Competitors

LakeShore Biopharma (NASDAQ:LSB) and Heatwurx (NASDAQ:PCSA) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

LakeShore Biopharma's return on equity of 0.00% beat Heatwurx's return on equity.

Company Net Margins Return on Equity Return on Assets
LakeShore BiopharmaN/A N/A N/A
Heatwurx N/A -319.56%-232.40%

Heatwurx has a consensus target price of $2.00, suggesting a potential upside of 784.17%. Given Heatwurx's stronger consensus rating and higher probable upside, analysts clearly believe Heatwurx is more favorable than LakeShore Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LakeShore Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Heatwurx
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Heatwurx has lower revenue, but higher earnings than LakeShore Biopharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LakeShore Biopharma$80.82MN/A-$61.09MN/AN/A
HeatwurxN/AN/A-$11.85M-$3.08-0.07

In the previous week, LakeShore Biopharma had 2 more articles in the media than Heatwurx. MarketBeat recorded 3 mentions for LakeShore Biopharma and 1 mentions for Heatwurx. Heatwurx's average media sentiment score of 1.89 beat LakeShore Biopharma's score of 0.84 indicating that Heatwurx is being referred to more favorably in the news media.

Company Overall Sentiment
LakeShore Biopharma Positive
Heatwurx Very Positive

52.6% of LakeShore Biopharma shares are owned by institutional investors. Comparatively, 91.9% of Heatwurx shares are owned by institutional investors. 9.6% of Heatwurx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

LakeShore Biopharma has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Heatwurx has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500.

Summary

Heatwurx beats LakeShore Biopharma on 8 of the 12 factors compared between the two stocks.

Get Heatwurx News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PCSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PCSA vs. The Competition

MetricHeatwurxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.69M$2.42B$5.56B$9.11B
Dividend YieldN/A1.79%5.06%4.01%
P/E Ratio-0.079.4228.2620.26
Price / SalesN/A732.10435.95101.33
Price / CashN/A164.4637.1257.67
Price / Book0.494.608.045.49
Net Income-$11.85M$31.26M$3.19B$250.45M
7 Day Performance17.20%4.80%3.62%4.78%
1 Month Performance-12.50%8.17%5.98%9.58%
1 Year Performance-87.43%-3.88%29.39%16.41%

Heatwurx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PCSA
Heatwurx
3.201 of 5 stars
$0.23
-1.6%
$2.00
+784.2%
-87.4%$2.69MN/A-0.0720Positive News
Gap Down
LSB
LakeShore Biopharma
0.7382 of 5 stars
$0.99
-0.4%
N/A-77.0%$9.26M$80.82M0.00773News Coverage
Gap Down
TLPH
Talphera
2.0108 of 5 stars
$0.46
+2.7%
$5.00
+979.9%
-44.1%$9.25M$650K-1.0319Positive News
DWTX
Dogwood Therapeutics
2.2469 of 5 stars
$4.60
-4.2%
$10.00
+117.4%
N/A$9.17MN/A-0.255News Coverage
AEON
AEON Biopharma
2.426 of 5 stars
$0.79
-5.5%
$360.00
+45,371.8%
-99.2%$8.95MN/A4.405News Coverage
NLSP
NLS Pharmaceutics
N/A$2.27
-7.0%
N/A+956.3%$8.78MN/A0.006
CLRB
Cellectar Biosciences
2.564 of 5 stars
$4.80
flat
$375.00
+7,712.5%
-93.6%$8.69MN/A-0.2210Positive News
CHRO
Chromocell Therapeutics
N/A$1.34
+6.3%
N/A-88.3%$8.69MN/A-1.084Gap Up
High Trading Volume
KPRX
Kiora Pharmaceuticals
3.2272 of 5 stars
$2.81
-1.4%
$10.00
+255.9%
-28.9%$8.68MN/A-0.9710Positive News
TSBX
Turnstone Biologics
2.6018 of 5 stars
$0.37
+0.9%
$0.45
+23.3%
-85.0%$8.37MN/A-0.1382
BMRA
Biomerica
1.1328 of 5 stars
$3.40
+4.0%
N/A+10.3%$8.32M$5.41M-1.4760

Related Companies and Tools


This page (NASDAQ:PCSA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners